Phoenix Motor Acquires Hydrogen Cell Assets From Altergy Systems
August 22, 11:42 AM
Phoenix Motor Inc (NASDAQ:PEV) has acquired hydrogen fuel cell manufacturing assets from Altergy Systems. The details of the transaction were not disclosed.…
Kronos Bio Shares Fall After Initial-Stage Blood Cancer Study Takes-off
August 22, 11:39 AM
Kronos Bio (NASDAQ: KRON) has initiated patient dosing in a Phase 1b/2 clinical trial of lanraplenib in combination with gilteritinib in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia (AML).
Minerva Seeks FDA Approval For Its Schizophrenia Candidate
August 22, 11:38 AM
Minerva Neurosciences Inc (NASDAQ:NERV) submitted a marketing application to the FDA for roluperidone for negative symptoms in patients with schizophrenia. “We…
Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here’s Who May Be Rolling Them Out
August 22, 11:36 AM
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have completed a submission to the FDA requesting Emergency Use Authorization for an omicron BA.4/BA.5-adapted COVID-19…
Belite Bio Starts Enrollment In Pivotal Lead Asset Study In Inherited Eye Disease
August 22, 11:27 AM
Belite Bio Inc (NASDAQ:BLTE) commenced enrollment for the U.S. Phase 3 trial of LBS-008 in patients with Stargardt Disease (STGD1), a…
Gilead’s Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays
August 22, 11:25 AM
The European Commission has approved Gilead Sciences Inc’s (NASDAQ:GILD) lenacapavir for adults with multi-drug resistant HIV infection. The drug, branded as…